These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26950108)

  • 1. Nanotechnology Formulations for Antibacterial Free Fatty Acids and Monoglycerides.
    Jackman JA; Yoon BK; Li D; Cho NJ
    Molecules; 2016 Mar; 21(3):305. PubMed ID: 26950108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides.
    Tan JYB; Yoon BK; Cho NJ; Lovrić J; Jug M; Jackman JA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Free Fatty Acids and Monoglycerides: Biological Activities, Experimental Testing, and Therapeutic Applications.
    Yoon BK; Jackman JA; Valle-González ER; Cho NJ
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial lipids in nano-carriers for antibacterial delivery.
    Zhang Q; Wu W; Zhang J; Xia X
    J Drug Target; 2020 Mar; 28(3):271-281. PubMed ID: 31613147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic.
    Cheung Lam AH; Sandoval N; Wadhwa R; Gilkes J; Do TQ; Ernst W; Chiang SM; Kosina S; Howard Xu H; Fujii G; Porter E
    BMC Res Notes; 2016 Jul; 9():337. PubMed ID: 27391402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antimicrobial activity of a blend of monoglycerides against Escherichia coli and Enterococci with multiple drug resistance.
    Anacarso I; Quartieri A; De Leo R; Pulvirenti A
    Arch Microbiol; 2018 Jan; 200(1):85-89. PubMed ID: 28799127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal effects of fatty acids and monoglycerides on Helicobacter pylori.
    Bergsson G; Steingrímsson O; Thormar H
    Int J Antimicrob Agents; 2002 Oct; 20(4):258-62. PubMed ID: 12385681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review of medium chain monoglycerides on metabolic pathways, nutritional and functional properties, nanotechnology formulations and applications in food system.
    Yang M; Zhang J; Yan H; Pan Y; Zhou J; Zhong H; Wang J; Cai H; Feng F; Zhao M
    Crit Rev Food Sci Nutr; 2024 May; ():1-22. PubMed ID: 38779723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of self-assemblies of new omega-3 lipids: docosahexaenoic acid and docosapentaenoic acid monoglycerides.
    Shao X; Bor G; Al-Hosayni S; Salentinig S; Yaghmur A
    Phys Chem Chem Phys; 2018 Oct; 20(37):23928-23941. PubMed ID: 30209464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient.
    Kristmundsdóttir T; Arnadóttir SG; Bergsson G; Thormar H
    J Pharm Sci; 1999 Oct; 88(10):1011-5. PubMed ID: 10514348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems.
    Ahmed AR; Dashevsky A; Bodmeier R
    Eur J Pharm Biopharm; 2010 Aug; 75(3):375-80. PubMed ID: 20403431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative antimicrobials: the properties of fatty acids and monoglycerides.
    Churchward CP; Alany RG; Snyder LAS
    Crit Rev Microbiol; 2018 Sep; 44(5):561-570. PubMed ID: 29733249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-in-oil microemulsions versus emulsions as carriers of hydroxytyrosol: an in vitro gastrointestinal lipolysis study using the pHstat technique.
    Chatzidaki MD; Mateos-Diaz E; Leal-Calderon F; Xenakis A; Carrière F
    Food Funct; 2016 May; 7(5):2258-69. PubMed ID: 27164003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial study of the medium chain fatty acids and their 1-monoglycerides: individual effects and synergistic relationships.
    Batovska DI; Todorova IT; Tsvetkova IV; Najdenski HM
    Pol J Microbiol; 2009; 58(1):43-7. PubMed ID: 19469285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated aliphatic alcohols as synthetic precursors of ultra long-chain monoacylglycerols for cosmetic applications.
    Pérez B; Hansen BS; Bulsara PA; Rawlings AV; Clarke MJ; Guo Z
    Int J Cosmet Sci; 2017 Oct; 39(5):511-517. PubMed ID: 28493610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential.
    Desbois AP; Smith VJ
    Appl Microbiol Biotechnol; 2010 Feb; 85(6):1629-42. PubMed ID: 19956944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid injectable emulsions: 2006.
    Driscoll DF
    Nutr Clin Pract; 2006 Aug; 21(4):381-6. PubMed ID: 16870806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.